Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03381274
Title Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site San Francisco California 94143 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site New Haven Connecticut 06510 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Chicago Illinois 60611 United States Details
Research Site Baltimore Maryland 21224 United States Details
Research Site New York New York 10032 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Taichung 40705 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field